top
Search terms
Results 61 - 70 of 156 - ordered by :
Pages: 1 ... 4 5 6 7 8 9 10 ... 16
Eurointervention

EuroIntervention Two-year outcomes of an everolimus-eluting BRS in real-world coronary artery disease Robaei D., Spies M., Back L., Kushwaha V., Ooi S., Giles R., Pitney M., Jepson N. AIMS To ...

Date : 06/05/2016 Item size : 32778 bytes
Eurointervention

EuroIntervention Impact of stent type and prolonged DAPT on long-term clinical outcomes in haemodialysis patients with coronary artery disease Asami M., Aoki J., Sato T., Tanimoto S., Watanabe M., ...

Date : 06/05/2016 Item size : 31385 bytes
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 21/04/2016
Heart

David M Shavelle Correspondence to David M Shavelle, Division of Cardiovascular Medicine, University of Southern California, 1510 San Pablo Street, Suite 322, Los Angeles, CA 90033, USA; ...

Heart, Review, David M Shavelle

Date : 01/04/2016
Eurointervention

EuroIntervention Prolonged dual antiplatelet therapy: a potential mitigator of the adverse effects of local haemodynamic shear stress in high-risk coronary regions? Additionally, the benefits of ...

Date : 12/02/2016 Item size : 66621 bytes
Eurointervention

EuroIntervention Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet ...

Date : 12/02/2016 Item size : 35796 bytes
Ehjournal

[...]patients with renal insufficiency have a particularly high risk of coronary events, actually higher than that of most diabetic patients.2 Second, the interaction between renal failure and ...

European Heart Journal, Editorial, Nicolas Danchin, Etienne Puymirat, François Schiele

Date : 21/01/2016 Item size : 184766 bytes
Ehjournal

Methods and results Patients (N = 1799) who had undergone placement of 1 DES for stable coronary artery disease or acute coronary syndrome were included in 58 French sites (January 2009January ...

European Heart Journal, FASTTRACK CLINICAL RESEARCH, Gérard Helft, Philippe Gabriel Steg, Claude Le Feuvre, Jean-Louis Georges, Didier Carrie, Xavier Dreyfus, Alain Furber, Florence Leclercq, ...

Date : 21/01/2016
Ehjournal

Abstract Aims In the dual antiplatelet therapy (DAPT) study, continued thienopyridine beyond 12 months after drug-eluting stent placement was associated with increased mortality compared with ...

European Heart Journal, CLINICAL RESEARCH, Laura Mauri, Sammy Elmariah, Robert W. Yeh, Donald E. Cutlip, P. Gabriel Steg, Stephan Windecker, Stephen D. Wiviott, David J. Cohen, Joseph M. Massaro, ...

Date : 21/01/2016
Ehjournal

The duration of 12 months of DAPT was accepted, recommended, and reproduced in subsequent trials when more potent P2Y12 inhibitors were studied in NSTE-ACS.11,13 In the pivotal studies for ...

European Heart Journal, Review, Gilles Montalescot, Marc S. Sabatine

Date : 21/01/2016